X
Search
X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

ZERO News

Cancer Mortality Rates Vary Among Major Hispanic Ethnic Groups

Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major ...
News Medical /

Metastatic Prostate Cancer Death Rates Declining

Mortality rates from metastatic prostate cancer (mPCa) are declining, researchers concluded in a poster presentation at the 2017 Genitourinary Cancers ...

Explaining Androgen Receptor-indifferent Prostate Cancer

The evidence base for the existence of androgen receptor (AR)-“indifferent” cell states in some prostate tumors is growing stronger, according ...

Development of a New Nomogram to Predict Insignificant Prostate Cancer in Patients Undergoing Radical Prostatectomy

The aim of this study was to develop a nomogram to predict the probability of insignificant prostate cancer. Read more ...

Genomic Test Predicts Metastasis, Mortality in Prostate Cancer

The genomic-based Decipher test effectively predicted metastasis and prostate cancer-specific mortality (PCSM) from diagnostic biopsy specimens for patients with intermediate- ...

New Research Suggests Broader Genetic Testing of Prostate Cancer Patients May be Warranted to Identify Risk of an Inherited Mutation That Might Inform Treatment

New research suggests that a substantial fraction of patients with prostate cancer and a positive family history are at high ...
doctorpatienttreatmentrisk_1144555

Immunotherapy and the Future of Prostate Cancer Treatment

Despite early failures, there may be a role for single-agent and combination immunotherapy for patients with prostate cancer, according to ...

Mitoxantrone/Prednisone Fails to Improve Outcomes When Added to ADT in High-Risk Prostate Cancer

Adding mitoxantrone and prednisone (MP) to androgen-deprivation therapy (ADT) in patients with high-risk prostate cancer who underwent prostatectomy increased the ...

Prostate Cancer Can Be Distinguished Into Luminal, Basal Subtypes, Potentially Guiding Therapy

Prostate cancer can be subtyped based on cell of origin, into luminal A, luminal B, and basal cell subtypes, according ...

Higher BMI Lowers Death Risk in Men With Advanced Prostate Cancer

Higher body mass index (BMI) is independently associated with improved survival of patients with metastatic and castration-resistant prostate cancer (PCa), ...

Phase III Results Support Novel Focal Therapy for Low-Risk Prostate Cancer

Padeliporfin vascular-targeted photodynamic therapy, a novel tissue-preserving treatment, may offer men with low-risk prostate cancer a safe and effective alternative ...

Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted Therapeutic Candidate 1095 For the Treatment of Metastatic Prostate Cancer

Progenics Pharmaceuticals, Inc., an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that ...
Print

Stakeholders Applaud USPSTF for Including Urologist in Review Process for Updated Prostate Cancer Recommendations

LINTHICUM, Md., Feb. 14, 2017 /PRNewswire-USNewswire/ -- As part of an ongoing commitment to maintaining patient access to prostate cancer ...

Liquid Biopsy Shows Promise in Advanced Prostate Cancer

“Liquid biopsy” analyses of circulating tumor DNA (ctDNA) from blood samples potentially reveal prognostic information about metastatic castration-resistant prostate cancer ...

Low Vitamin D Predicts Aggressive Prostate Cancer

A recent study provides a major link between low levels of vitamin D and aggressive prostate cancer. Northwestern Medicine research ...

Non-Profit Drug Development Could Cut Cost of Cancer Medicines

Universities should work with new forms of commercial partner to take their own cancer drugs to market and drive down ...

Scientists Discover ‘Achilles’ Heel’ of Tumor-Suppressing Protein That Drives Prostate Cancer Metastasis

Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered that a protein called Importin-11 protects the anti-cancer protein PTEN from ...

Kettering Project Using Skype and FaceTime to Help Prostate Cancer Patients

Specialist nurses at Kettering General Hospital are using skype and facetime as a way of communicating with concerned patients at ...

Prostate Cancer Risk Stratification Enhanced by Novel MRI Protocol

Targeted prostate biopsy based on the findings of a novel biparametric magnetic resonance imaging (bpMRI) protocol improves risk stratification among ...

Surgery, Radiation, or Active Surveillance? Findings From the ProtecT Trial for Prostate Cancer

Findings From the ProtecT Trial for Prostate Cancer. Read more ...

Current BRCA1/2 Genetic Testing Guidelines for Prostate Cancer and the Implications for Oncologists

Current BRCA1/2 genetic testing guidelines for prostate cancer and the implications for oncologists. Read more ...

Combo Therapy May Help Those Whose Prostate Cancer Recurs After Gland Removed

Men who show biochemical signs that their prostate cancer is recurring after removal of their prostate may live years longer ...

Radical Prostatectomy Neutralizes Obesity-Driven Risk of Prostate Cancer Progression

Obese prostate cancer patients may be at higher risk of having the disease spread to other organs, according to a ...

Search for Synthetic-Essential Genes Uncovers Prostate Cancer Treatment Target

A new method has been found for identifying therapeutic targets in cancers lacking specific key tumor suppressor genes. The process, ...

More Resources